Page last updated: 2024-08-22

tiletamine hydrochloride and kp372-1

tiletamine hydrochloride has been researched along with kp372-1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Higashihara, M; Horie, R; Itoh, K; Masuda, N; Togano, T; Umezawa, K; Watanabe, M1

Other Studies

1 other study(ies) available for tiletamine hydrochloride and kp372-1

ArticleYear
Activation of Akt involves resistance to NF-κB inhibition and abrogation of both triggers synergistic apoptosis in lung adenocarcinoma cells.
    Lung cancer (Amsterdam, Netherlands), 2014, Volume: 83, Issue:2

    Topics: Adenocarcinoma; Aged; Apoptosis; Benzamides; Cell Survival; Cells, Cultured; Cyclohexanones; Drug Synergism; Female; Heterocyclic Compounds, 4 or More Rings; Humans; Lung Neoplasms; Male; Mechanistic Target of Rapamycin Complex 1; Middle Aged; Multiprotein Complexes; Neoplasm Staging; NF-kappa B; Oncogene Protein v-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Tetrazoles; TOR Serine-Threonine Kinases

2014